Search research articles
Contact Us
Filters
Showing results (101-110 of 133) with videos related to
Page
of 14
Sort By:
Dementia and Geriatric Cognitive Disorders Extra
|
November 1, 2013
Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementia
Martin R Farlow, Frederick Schmitt, Dag Aarsland, et al.
Alzheimer Disease and Associated Disorders
|
December 2, 2014
A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease
Martin R Farlow, George T Grossberg, Carl H Sadowsky, et al.
Alzheimer Disease and Associated Disorders
|
May 18, 2018
Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors
George T Grossberg, Gustavo Alva, Suzanne Hendrix, et al.
Current Nutrition Reports
|
March 29, 2022
Comparison of the Impact of the Mediterranean Diet, Anti-Inflammatory Diet, Seventh-Day Adventist Diet, and Ketogenic Diet Relative to Cognition and Cognitive Decline
Jennifer To, Zi Yi Shao, Monique Gandawidjaja, et al.
Current Medical Research and Opinion
|
December 23, 2003
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors
Serge Gauthier, Murat Emre, Martin R Farlow, et al.
Journal of the American Medical Directors Association
|
July 7, 2026
Validation and Reliability of the "SLU-AMSAD" Depression Scale in Individuals With Dementia
Mehmet Selman Ontan, Kadriye Petek Yakar, Burcu Akpinar Soylemez, et al.
Current Medical Research and Opinion
|
January 14, 2026
Brexpiprazole side-effect profile in people with agitation in Alzheimer's dementia: a plain language summary
Alpesh Shah, Uwa Kalu, Dalei Chen, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
February 7, 2014
Impact of exogenous testosterone on mood: a systematic review and meta-analysis of randomized placebo-controlled trials
Hamid R Amanatkar, John T Chibnall, Byung-Woun Seo, et al.
JAMA
|
January 22, 2004
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial
Pierre N Tariot, Martin R Farlow, George T Grossberg, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
December 16, 2014
Development of a brief validated geriatric depression screening tool: the SLU "AM SAD"
Binu Chakkamparambil, John T Chibnall, Ernest A Graypel, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 133) with videos related to
Sort By:
Page
of 14
Dementia and Geriatric Cognitive Disorders Extra
|
November 1, 2013
Comparing clinical profiles in Alzheimer's disease and Parkinson's disease dementia
Martin R Farlow, Frederick Schmitt, Dag Aarsland, et al.
Alzheimer Disease and Associated Disorders
|
December 2, 2014
A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease
Martin R Farlow, George T Grossberg, Carl H Sadowsky, et al.
Alzheimer Disease and Associated Disorders
|
May 18, 2018
Memantine ER Maintains Patient Response in Moderate to Severe Alzheimer's Disease: Post Hoc Analyses From a Randomized, Controlled, Clinical Trial of Patients Treated With Cholinesterase Inhibitors
George T Grossberg, Gustavo Alva, Suzanne Hendrix, et al.
Current Nutrition Reports
|
March 29, 2022
Comparison of the Impact of the Mediterranean Diet, Anti-Inflammatory Diet, Seventh-Day Adventist Diet, and Ketogenic Diet Relative to Cognition and Cognitive Decline
Jennifer To, Zi Yi Shao, Monique Gandawidjaja, et al.
Current Medical Research and Opinion
|
December 23, 2003
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors
Serge Gauthier, Murat Emre, Martin R Farlow, et al.
Journal of the American Medical Directors Association
|
July 7, 2026
Validation and Reliability of the "SLU-AMSAD" Depression Scale in Individuals With Dementia
Mehmet Selman Ontan, Kadriye Petek Yakar, Burcu Akpinar Soylemez, et al.
Current Medical Research and Opinion
|
January 14, 2026
Brexpiprazole side-effect profile in people with agitation in Alzheimer's dementia: a plain language summary
Alpesh Shah, Uwa Kalu, Dalei Chen, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists
|
February 7, 2014
Impact of exogenous testosterone on mood: a systematic review and meta-analysis of randomized placebo-controlled trials
Hamid R Amanatkar, John T Chibnall, Byung-Woun Seo, et al.
JAMA
|
January 22, 2004
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial
Pierre N Tariot, Martin R Farlow, George T Grossberg, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
December 16, 2014
Development of a brief validated geriatric depression screening tool: the SLU "AM SAD"
Binu Chakkamparambil, John T Chibnall, Ernest A Graypel, et al.
Page
of 14